Market Analysis Report 2024-2032

Point of Care Diagnostics Market

Global Market Growth from USD 31.57B (2024) to USD 51.19B (2032)

Market Size 2024

USD 31.57B

Global valuation

Projected 2032

USD 51.19B

Market forecast

CAGR Growth

6.2%

2024-2032 period

Regional Leader

35.37%

North America share

Market Overview

The global Point of Care Diagnostics Market is experiencing significant growth driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for rapid diagnostic solutions. Point of care testing (POCT) refers to testing conducted close to the site of patient care where care or treatment is provided, enabling healthcare providers to deliver faster and more efficient patient care.

The market was valued at USD 31.57 billion in 2024 and is projected to grow from USD 32.87 billion in 2025 to USD 51.19 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period. This robust growth is fueled by several factors including the rising prevalence of conditions such as cardiac disorders, diabetes, and infectious diseases, coupled with the benefits of quick results and operational efficiency that POCT provides.

Key Insight:

According to 2021 data published by the Centers for Disease Control and Prevention (CDC), there are approximately 38.4 million people with diabetes in the U.S., driving significant demand for blood glucose monitoring and related POCT solutions.

Global Market Size Projection (2023-2032)

Market value in USD Billions

Regional Market Share (2023)

Distribution across major regions

Product Segment Distribution

Market breakdown by product type

Market Trends & Drivers

🔬Technological Advancements

Major market players are increasingly adopting advanced technologies such as artificial intelligence, IoT, and machine learning to manufacture efficient diagnostic tests. In November 2023, F. Hoffmann-La Roche Ltd. launched Elecsys HBeAg quant, an immunoassay that can determine the presence and quantity of the hepatitis Be antigen (HBeAg) in human serum and plasma.

📱Miniaturization & Mobility

POC testing devices now include advanced features such as miniaturization and increased mobility. These advancements are enabling bioassays, including microbiological culture, Enzyme-Linked Immunosorbent Assays (ELISA), and polymerase Chain Reaction (PCR) tests to be performed at the point of care.

🏥Rising Disease Prevalence

The increasing prevalence of conditions such as cardiac disorders, diabetes, and infectious diseases is driving the demand for POCT. The benefits of quick results and operational efficiency make these tests essential in modern healthcare delivery.

💡COVID-19 Impact & Recovery

The COVID-19 pandemic positively impacted the market for point-of-care diagnostics in 2020, with rapid testing significantly increasing demand. However, the market witnessed slower growth in 2021 due to reduced COVID-19 cases and vaccine rollouts globally.

Market Infographic

End-User Applications

Hospital Bedside

Rapid testing at patient bedside for immediate clinical decisions

Physician's Office Lab

Point-of-care testing in clinical settings for faster diagnosis

Urgent Care & Retail Clinics

Quick diagnostic solutions in walk-in and retail healthcare facilities

Home & Self-Testing

Patient-friendly devices for home-based monitoring and testing

Get Detailed Market Insights

Access comprehensive analysis, detailed segmentation, and strategic recommendations from Fortune Business Insights.

Report Details

Report ID: FBI101072
Last Updated: April 14, 2025
Format: PDF
Forecast Period: 2024-2032

Coverage

Global Market Analysis
Regional Breakdown
Product Segmentation
Competitive Landscape

Source

All data and insights sourced from Fortune Business Insights comprehensive market research.

View Full Report →